Synergism of Anti-CGRP Monoclonal Antibodies and OnabotulinumtoxinA in the Treatment of Migraine

被引：0
|
作者：
Hennessy, Elise [1 ]
Salim, Amira [1 ]
Biswas, Sudipa [1 ]
Suneja, Aarushi [1 ]
Mays, Maryann [1 ]
Ahmed, Zubair [1 ]
Mata, Ignacio [1 ]
机构：
[1] Cleveland Clin, Cleveland, OH USA
来源：
NEUROLOGY | 2023年 / 100卷 / 17期
关键词：
D O I：
10.1212/WNL.0000000000203028
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P10-12.005
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Synergism of anti-CGRP monoclonal antibodies and onabotulinumtoxinA in the treatment of migraine
    Hennessy, E.
    Salim, A.
    Biswas, S.
    Sonneborn, C.
    Hogue, O.
    Suneja, A.
    Mays, M.
    Ahmed, Z.
    Mata, I
    HEADACHE, 2023, 63 : 170 - 171
  • [2] Synergism of Anti-CGRP Monoclonal Antibodies and OnabotulinumtoxinA in the Treatment of Chronic Migraine: A Real-World Retrospective Chart Review
    Amira Salim
    Elise Hennessy
    Claire Sonneborn
    Olivia Hogue
    Sudipa Biswas
    MaryAnn Mays
    Aarushi Suneja
    Zubair Ahmed
    Ignacio F. Mata
    CNS Drugs, 2024, 38 : 481 - 491
  • [3] Synergism of Anti-CGRP Monoclonal Antibodies and OnabotulinumtoxinA in the Treatment of Chronic Migraine: A Real-World Retrospective Chart Review
    Salim, Amira
    Hennessy, Elise
    Sonneborn, Claire
    Hogue, Olivia
    Biswas, Sudipa
    Mays, Maryann
    Suneja, Aarushi
    Ahmed, Zubair
    Mata, Ignacio F.
    CNS DRUGS, 2024, 38 (06) : 481 - 491
  • [4] OnabotulinumtoxinA add-on to monoclonal anti-CGRP antibodies in treatment-refractory chronic migraine
    Dermitzakis, E.
    Argyriou, A.
    Xiromerisiou, G.
    Vikelis, M.
    JOURNAL OF HEADACHE AND PAIN, 2024, 25
  • [5] OnabotulinumtoxinA Add-On to Monoclonal Anti-CGRP Antibodies in Treatment-Refractory Chronic Migraine
    Argyriou, Andreas A. A.
    Dermitzakis, Emmanouil V. V.
    Xiromerisiou, Georgia
    Vikelis, Michail
    TOXINS, 2022, 14 (12)
  • [6] The Arrival of Anti-CGRP Monoclonal Antibodies in Migraine
    Fred Cohen
    Hsiangkuo Yuan
    E. M. G. DePoy
    Stephen D. Silberstein
    Neurotherapeutics, 2022, 19 : 922 - 930
  • [7] The association between onabotulinumtoxinA and anti-CGRP monoclonal antibodies: a reliable option for the optimal treatment of chronic migraine
    Guerzoni, Simona
    Baraldi, Carlo
    Pani, Luca
    NEUROLOGICAL SCIENCES, 2022, 43 (09) : 5687 - 5695
  • [8] The association between onabotulinumtoxinA and anti-CGRP monoclonal antibodies: a reliable option for the optimal treatment of chronic migraine
    Simona Guerzoni
    Carlo Baraldi
    Luca Pani
    Neurological Sciences, 2022, 43 : 5687 - 5695
  • [9] Switching OnabotulinumtoxinA to Monoclonal Anti-CGRP Antibodies in Drug-Resistant Chronic Migraine
    Luigi Francesco Iannone
    Davide Fattori
    Martina Marangoni
    Silvia Benemei
    Alberto Chiarugi
    Pierangelo Geppetti
    Francesco De Cesaris
    CNS Drugs, 2023, 37 : 189 - 202
  • [10] The Arrival of Anti-CGRP Monoclonal Antibodies in Migraine
    Cohen, Fred
    Yuan, Hsiangkuo
    DePoy, E. M. G.
    Silberstein, Stephen D.
    NEUROTHERAPEUTICS, 2022, 19 (03) : 922 - 930
12345